The responses to the survey questions will be used as the foundation of the dinner conversation.

Question Title

* 1. Please enter in your information below. Thank you!

Question Title

* 2. Which tumour type is your company or institution developing cellular genetic immunotherapies against? (select all that apply)

Question Title

* 3. Which engineered cell type (s) have the biggest chance of long term success against solid tumours:

Question Title

* 4. Please rate these challenges. Most important (1) to least (4)

Question Title

* 5. Do you think Autologous cell based immunotherapies may overtake Allogeneic immunotherapies in the future?

Question Title

* 6. If you work with viral vectors do you:

Question Title

* 7. Do you think other methods will surpass viral vectors as the method of choice for inserting genes into cells?

Question Title

* 8. How important is it to have GMP reagents, devices and instruments throughout your Research and Manufacturing Processes? (select all that apply)

Question Title

* 9. Are you interested in validating newer methodologies that offer better accuracy and precision for key assays as part of your cellular/immunotherapy manufacturing and QC processes?

T